The prevalence of clarithromycin-resistant Helicobacter pylori isolates: a systematic review and meta-analysis
PeerJ · 30.03.2023 · 11 · e15121
DOI: 10.7717/peerj.15121 ↗Kurz gefasst
Metaanalyse in der Zeitschrift PeerJ, online erschienen am 30.03.2023. Verfasst von Mohammad Sholeh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Pasteur Institute of Iran, Tehran, Iran. Hauptthemen laut MEDLINE: Helicobacter pylori, Helicobacter Infections. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 274 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Knowledge of global clarithromycin (CLA)-resistant rates of Helicobacter pylori ( H. pylori ) is crucial for decision of the most appropriate eradication therapies with good clinical outcomes. Therefore, this review and meta-analysis aimed to evaluate the global prevalence of the CLA resistance in H. pylori to provide some guidance for selecting the first-line antibiotics.
Method
A comprehensive search was performed for relevant literature until April 2021 in PubMed, Embase, and Web of Science databases. Freeman-Tukey double arcsine transformation was performed to estimate the weighted pooled prevalence of resistance.
Results
The meta-analysis included 248 articles. The prevalence of CLA-resistant H. pylori was 27.53% (95% CI [25.41–29.69]). The heterogeneity between reports was significant (I 2 = 97.80%, P < 0.01). The resistance rate increased from 24.28% in 2010–2017 to 32.14% in 2018–2021 ( P < 0.01). Iran, with 38 articles, has the most report. Nevertheless, Switzerland, Portugal, and Israel had the highest resistance rates (67.16%, 48.11%, and 46.12%, respectively). The heterogeneity between the continents and the antimicrobial susceptibility methods also interpreted standard guidelines and breakpoints was insignificant ( P > 0.05).
Conclusion
Overall CLA resistance rate was 27.53%, worldwide. The difference in CLA resistance rate among the included studies can be due to several reasons such as differences in antibiotic prescription rates in various geographic areas, use of different breakpoints or inaccurate criteria in performed studies, and the emergence of multidrug-resistant (MDR) strains.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Pasteur Institute of Iran, Tehran, Iran.
- Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran.
- Student Research Committee, Ilam University of Medical Sciences, Ilam, Iran.
- Department of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Pediatrics, School of Medicine, Emam Khomeini Hospital, Ilam University of Medical Sciences, Ilam, Iran.
- Department of Microbiology, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
ORCID-Profile: Morteza Saki
Zitieren
APA
Sholeh, M., Khoshnood, S., Azimi, T., Mohamadi, J., Kaviar, V. H., Hashemian, M., Karamollahi, S., Sadeghifard, N., Heidarizadeh, H., Heidary, M., & Saki, M. (2023). The prevalence of clarithromycin-resistant Helicobacter pylori isolates: a systematic review and meta-analysis. PeerJ, 11, e15121. https://doi.org/10.7717/peerj.15121
Vancouver
Sholeh M, Khoshnood S, Azimi T, Mohamadi J, Kaviar VH, Hashemian M, et al. The prevalence of clarithromycin-resistant Helicobacter pylori isolates: a systematic review and meta-analysis. PeerJ. 2023;11:e15121. doi:10.7717/peerj.15121
BibTeX
@article{Sholeh2023,
author = {Sholeh, Mohammad and Khoshnood, Saeed and Azimi, Taher and Mohamadi, Jasem and Kaviar, Vahab Hassan and Hashemian, Marzieh and Karamollahi, Somayeh and Sadeghifard, Nourkhoda and Heidarizadeh, Hedayat and Heidary, Mohsen and Saki, Morteza},
title = {The prevalence of clarithromycin-resistant Helicobacter pylori isolates: a systematic review and meta-analysis},
journal = {PeerJ},
year = {2023},
volume = {11},
pages = {e15121},
doi = {10.7717/peerj.15121}
}
EUVIMED